|2000||The idea of creating a body that would improve European image-related research activities was born. It emerged within the former European Association of Radiology (EAR) which was later integrated into the European Society for Radiology (ESR).|
An ad hoc committee was created to supervise imaging research activities in Europe, and to offer advice to the EAR on how to establish a body with the goal of improving and co-ordinating imagingrelated research activities in Europe.
|2004||At the European Congress of Radiology (ECR) in 2004 the ad hoc committee presented an overview of the existing research infrastructures throughout Europe, developing modules for research education as well as creating a database of centres performing basic imaging-related research. The committee recommended determining societies and organisations as partners in order to properly establish a pan-European research institute, analogous to the National Institute of Biomedical Imaging and Bioengineering, USA. Based on these recommendations a second ad hoc committee was created with the aim to build a network of research centres of excellence in biomedical imaging, and creating possibilities for the education and strengthening of biomedical imaging research and training throughout Europe.|
An action plan entitled “Towards a European Institute for Biomedical Imaging Research” was developed by the ad hoc committee and submitted within the 6th Framework Programme to the European Commission.
|2006||The action plan was approved by the European Commission and led to the official establishment of EIBIR as a non-profit limited liability company with its registered office in Vienna. EIBIR received financial support from a core group of industry partners in order to facilitate the establishment of its operational structures and to have some starting capital to initiate projects at a research level. Bayer Schering Pharma, Bracco, GE Healthcare, Philips and Siemens were the founding members of the EIBIR Industry Panel.|
EIBIR took over the co-ordination of two projects supported within the 7th Framework Programme with international consortia on cell imaging and tracking and breast cancer diagnosis and submitted two additional FP7 proposals.
|2009||By 2009 EIBIR’s Network and activities had grown to a point where there was a need for guidance of the various bodies and a strategic plan to ensure efficiency, viability, well-structured activities and a focused use of resources. Service packages were introduced for Network Members, Industry Partners and Shareholder Organisations to allow EIBIR to maintain and, consequently improve, its services.|